EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Phenotyping Sarcoidosis-Associated Pulmonary Hypertension: A Review of Pathophysiology and Management

Mohamed I Seedahmed iD, Jetina Okereke iD, Natalia V Rivera iD, Mazen O Al-Qadi

Therapeutic Advances in Pulmonary and Critical Care Medicine · 2026

DOI: 10.1177/29768675261485674 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Pulmonary and Critical Care Medicine, 2026. Verfasst von Mohamed I Seedahmed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Service, Pittsburgh Veterans Affairs Healthcare System, Pittsburgh, PA, USA; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicin…. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis-associated pulmonary hypertension (SAPH) is a significant yet often overlooked complication of sarcoidosis that profoundly affects both morbidity and mortality rates. The development of SAPH illustrates the intricate relationship among lung tissue damage, granulomatous inflammation of blood vessels, and remodeling of cardiac or vascular structures. This complexity highlights the multifaceted nature of sarcoidosis pathophysiology. In this review, we delve into key topics, including epidemiology, underlying mechanisms, and current treatment options, while also discussing the path forward for precision medicine applications. SAPH serves as a clear example of the systemic and vascular intricacies of sarcoidosis, connecting immune-mediated granulomatous inflammation with pulmonary vascular involvement. By gaining a deeper understanding of its unique molecular, hemodynamic, and imaging characteristics, we can enhance risk stratification and therapeutic decision-making, ultimately paving the way for more tailored management of sarcoidosis.

Schlagwörter

Stichwörter der Autor:innen

granulomatous vasculopathypulmonary arterial hypertension-targeted therapypulmonary vascular diseasesarcoidosissarcoidosis-associated pulmonary hypertension

Autor:innen und Institutionen

  • Medical Service, Pittsburgh Veterans Affairs Healthcare System, Pittsburgh, PA, USA; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Immunology and Respiratory Medicine, Department of Medicine Solna, Karolinska Institutet, Karolinska, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Mohamed I Seedahmed, Jetina Okereke, Natalia V Rivera

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Seedahmed, M. I., Okereke, J., Rivera, N. V., & Al-Qadi, M. O. (2026). Phenotyping Sarcoidosis-Associated Pulmonary Hypertension: A Review of Pathophysiology and Management. Therapeutic Advances in Pulmonary and Critical Care Medicine. https://doi.org/10.1177/29768675261485674

Vancouver

Seedahmed MI, Okereke J, Rivera NV, Al-Qadi MO. Phenotyping Sarcoidosis-Associated Pulmonary Hypertension: A Review of Pathophysiology and Management. Therapeutic Advances in Pulmonary and Critical Care Medicine. 2026. doi:10.1177/29768675261485674

BibTeX
@article{Seedahmed2026,
  author = {Seedahmed, Mohamed I and Okereke, Jetina and Rivera, Natalia V and Al-Qadi, Mazen O},
  title = {Phenotyping Sarcoidosis-Associated Pulmonary Hypertension: A Review of Pathophysiology and Management},
  journal = {Therapeutic Advances in Pulmonary and Critical Care Medicine},
  year = {2026},
  doi = {10.1177/29768675261485674}
}
Kostenlos starten →